Infection with Panresistant Klebsiella pneumoniae: A Report of 2 Cases and a Brief Review of the Literature

被引：125

作者：

Elemam, Azza ^{[1
]}

Rahimian, Joseph ^{[1
]}

Mandell, William ^{[1
]}

机构：

[1] St Vincents Hosp, Infect Dis Sect, New York, NY USA

来源：

CLINICAL INFECTIOUS DISEASES | 2009年 / 49卷 / 02期

关键词：

GRAM-NEGATIVE BACTERIA; NEW-YORK; RESISTANT; COLISTIN; CARBAPENEMASE;

D O I：

10.1086/600042

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Infections caused by carbapenemase-producing Klebsiella pneumoniae have been reported with increasing frequency, thereby limiting the choice of effective antimicrobial agents available to clinicians. This has prompted the increased use of polymyxins and tigecycline, but resistance to these agents is already emerging. We report 2 cases of infection with panresistant K. pneumoniae.

引用

页码：271 / 274

页数：4

共 15 条

[1] Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobactetiaceae
Anderson, K. F.
Lonsway, D. R.
Rasheed, J. K.
Biddle, J.
Jensen, B.
McDougal, L. K.
Carey, R. B.
Thompson, A.
Stocker, S.
Limbago, B.
Patel, J. B.
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (08) : 2723 - 2725
[2] Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients:: first report of a multiclonal cluster
Antoniadou, Anastasia
Kontopidou, Flora
Poulakou, Garifalia
Koratzanis, Evangelos
Galani, Irene
Papadomichelakis, Evangelos
Kopterides, Petros
Souli, Maria
Armaganidis, Apostolos
Giamarellou, Helen
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (04) : 786 - 790
[3] Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City
Bradford, PA
Bratu, S
Urban, C
Visalli, M
Mariano, N
Landman, D
Rahal, JJ
Brooks, S
Cebular, S
Quale, J
[J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (01) : 55 - 60
[4] Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York
Bratu, S
Landman, D
Alam, M
Tolentino, E
Quale, J
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (02) : 776 - 778
[5] Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI
[6] Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?
Falagas, Matthew E.
Bliziotis, Ioannis A.
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 (06) : 630 - 636
[7] Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria
Falagas, ME
Bliziotis, IA
Kasiakou, SK
Samonis, G
Athanassopoulou, P
Michalopoulos, A
[J]. BMC INFECTIOUS DISEASES, 2005, 5 (1)
[8] Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: Review of available interpretative criteria and quality control guidelines
Gales, AC
Reis, AO
Jones, RN
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (01) : 183 - 190
[9] The spread of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae to upstate New York
Lomaestro, BM
Tobin, EH
Shang, WC
Gootz, T
[J]. CLINICAL INFECTIOUS DISEASES, 2006, 43 (03) : E26 - E28
[10] Risk factors associated with the isolation of colistin-resistant Gyam-negative bacteria: A matched case-control study
Matthaiou, Dimitrios K.
Michalopoulos, Argyris
Rafailidis, Petros I.
Karageorgopoulos, Drosos E.
Papaioannou, Vassiliki
Ntani, Georgia
Samonis, George
Falagas, Mafthew E.
[J]. CRITICAL CARE MEDICINE, 2008, 36 (03) : 807 - 811

← 1 2 →